Serous Papillary Peritoneal Carcinoma: Unknown Primary Tumour, Ovarian Cancer Counterpart or a Distinct Entity? A Systematic Review
Differentiation in Serous Papillary Peritoneal Carcinomas
G Pentheroudakis, N Pavlidis
Yes
20100601
2010 Jul 1
Crit Rev Oncol Hematol
Serous Papillary Peritoneal Carcinoma: Unknown Primary Tumour, Ovarian Cancer Counterpart or a Distinct Entity? A Systematic Review
Crit Rev Oncol Hematol. 2010 Jul 1;75(1):27-42, G Pentheroudakis, N Pavlidis
Abstract
Abstract
Introduction: Serous peritoneal papillary carcinoma (SPPC), though managed according to ovarian cancer therapeutic principles, has been variably considered as an ovarian cancer counterpart, a peritoneal malignancy with distinct characteristics or a cancer of unknown primary (CUP). Patients and Methods: We systematically reviewed all publications studying molecular pathophysiology, clinical presentation, management and outcome of at least 10 patients with SPPC from 1980 to 2008 in anglophone medical...